| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 50.588 | 69.402 | 71.645 | 70.684 | 75.186 | 92.185 | 106.883 |
| Total Income - EUR | - | - | - | 50.589 | 69.403 | 71.647 | 70.685 | 75.199 | 92.189 | 112.830 |
| Total Expenses - EUR | - | - | - | 20.873 | 21.752 | 24.685 | 25.259 | 29.285 | 28.370 | 35.795 |
| Gross Profit/Loss - EUR | - | - | - | 29.715 | 47.651 | 46.962 | 45.426 | 45.914 | 63.819 | 77.035 |
| Net Profit/Loss - EUR | - | - | - | 29.210 | 46.956 | 46.545 | 44.804 | 45.177 | 62.916 | 74.013 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sanomedifam S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 6.503 | 4.690 | 2.952 | 1.275 | 1.253 | 21.240 | 18.281 |
| Current Assets | - | - | - | 24.329 | 43.681 | 69.144 | 83.099 | 48.810 | 88.978 | 79.211 |
| Inventories | - | - | - | 548 | 129 | 129 | 75 | 0 | 618 | 0 |
| Receivables | - | - | - | 4.186 | 5.955 | 5.519 | 6.593 | 33.898 | 66.719 | 50.092 |
| Cash | - | - | - | 19.595 | 37.596 | 63.497 | 76.431 | 14.912 | 21.641 | 8.038 |
| Shareholders Funds | - | - | - | 29.253 | 47.008 | 69.921 | 82.380 | 45.226 | 62.964 | 74.061 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.579 | 1.362 | 2.176 | 1.993 | 4.838 | 28.318 | 9.107 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 18.936 | 14.323 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanomedifam S.r.l.